GTS Securities’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25,000
Closed -$199K 1730
2025
Q2
$199K Buy
+25,000
New +$112K 0.01% 1127

Other funds holding VIGL

GTS Securities's VIGL Position: Q3 2025 in Review

GTS Securities sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 25,000 shares — an estimated $199K sold.

GTS Securities first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $199K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

  • GTS Securities reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
  • GTS Securities sold 25,000 Vigil Neuroscience shares in Q3 2025, an estimated $199K.
  • GTS Securities first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
  • GTS Securities's Vigil Neuroscience position peaked at $199K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.